ESR1 and breast cancer: In addition, a previous cohort study of ER-positive and HER2-negative T1N0M0 breast cancer from a Japanese institute reported that adjuvant ET did not improve DFS, DDFS, or OS for T1a/b disease, unlike T1c [26].